Continuous infusion of low dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer

V.M.M. Herben; W.W. ten Bokkel Huinink; M. Schot; I. Hudson; J.H. Beijnen

Continuous infusion of low dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer

V.M.M. Herben
, W.W. ten Bokkel Huinink
, M. Schot
, I. Hudson
, J.H. Beijnen

extern

Research output: Contribution to journal › Article › Academic › peer-review

Original language	Undefined/Unknown
Pages (from-to)	411-419
Number of pages	9
Journal	Anti-Cancer Drugs
Volume	9
Publication status	Published - 1998

Keywords

Medical technology
Farmacie(FARM)
Biomedische technologie en medicijnen
Public Health
Analytical chemistry
Drugmisbruik en verslaving

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Cite this

@article{77872242b7ed448c9b0f33c1906b1620,

title = "Continuous infusion of low dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer",

keywords = "Medical technology, Farmacie(FARM), Biomedische technologie en medicijnen, Public Health, Analytical chemistry, Drugmisbruik en verslaving",

author = "V.M.M. Herben and \{ten Bokkel Huinink\}, W.W. and M. Schot and I. Hudson and J.H. Beijnen",

year = "1998",

language = "Undefined/Unknown",

volume = "9",

pages = "411--419",

journal = "Anti-Cancer Drugs",

issn = "0959-4973",

publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Continuous infusion of low dose topotecan: pharmacokinetics and pharmacodynamics during a phase II study in patients with small cell lung cancer

AU - Herben, V.M.M.

AU - ten Bokkel Huinink, W.W.

AU - Schot, M.

AU - Hudson, I.

AU - Beijnen, J.H.

PY - 1998

Y1 - 1998

KW - Medical technology

KW - Farmacie(FARM)

KW - Biomedische technologie en medicijnen

KW - Public Health

KW - Analytical chemistry

KW - Drugmisbruik en verslaving

M3 - Article

SN - 0959-4973

VL - 9

SP - 411

EP - 419

JO - Anti-Cancer Drugs

JF - Anti-Cancer Drugs

ER -